AB
NTLA icon

Amalgamated Bank’s Intellia Therapeutics NTLA Stock Holding History

Amalgamated Bank’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,233
Closed -$29K – 2421
2025
Q4 		$29K Sell
3,233
-281
-8% -$3.87K ﹤0.01% 1979
2025
Q3 		$61K Hold
3,514
– – ﹤0.01% 1788
2025
Q2 		$33K Hold
3,514
– – ﹤0.01% 1952
2025
Q1 		$25K Buy
3,514
+367
+12% +$3.71K ﹤0.01% 1988
2024
Q4 		$37K Hold
3,147
– – ﹤0.01% 1915
2024
Q3 		$65K Hold
3,147
– – ﹤0.01% 1780
2024
Q2 		$70K Buy
3,147
+141
+5% +$3.36K ﹤0.01% 1787
2024
Q1 		$83K Sell
3,006
-5,571
-65% -$155K ﹤0.01% 1759
2023
Q4 		$262K Sell
8,577
-735
-8% -$21.1K ﹤0.01% 1711
2023
Q3 		$294K Buy
9,312
+219
+2% +$8.5K ﹤0.01% 1638
2023
Q2 		$371K Sell
9,093
-1,688
-16% -$68.5K ﹤0.01% 1573
2023
Q1 		$402K Sell
10,781
-2,344
-18% -$91.9K ﹤0.01% 1514
2022
Q4 		$458K Buy
13,125
+1,773
+16% +$84.3K ﹤0.01% 1499
2022
Q3 		$635K Buy
11,352
+222
+2% +$13.8K 0.01% 1316
2022
Q2 		$576K Sell
11,130
-290
-3% -$14.7K 0.01% 1399
2022
Q1 		$830K Sell
11,420
-855
-7% -$72.4K 0.01% 1298
2021
Q4 		$1.45M Buy
12,275
+30
+0.2% +$3.76K 0.01% 1078
2021
Q3 		$1.64M Buy
12,245
+182
+2% +$27.6K 0.01% 1019
2021
Q2 		$1.95M Buy
12,063
+4,253
+54% +$331K 0.02% 967
2021
Q1 		$627K Sell
7,810
-25
-0.3% -$1.68K 0.02% 855
2020
Q4 		$426K Buy
+7,835
New +$285K 0.02% 1053

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Amalgamated Bank's NTLA Position: Q1 2026 in Review

Amalgamated Bank sold out of Intellia Therapeutics (NTLA) in Q1 2026, closing a stake of 3,233 shares — an estimated $29K sold.

Amalgamated Bank first reported a position in NTLA in Q4 2020 and held it in 21 quarters. The position peaked at $1.95M in Q2 2021. 303 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • Amalgamated Bank reported no remaining Intellia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 3,233 Intellia Therapeutics shares in Q1 2026, an estimated $29K.
  • Amalgamated Bank first reported a position in Intellia Therapeutics in Q4 2020 and held it in 21 quarters.
  • Amalgamated Bank's Intellia Therapeutics position peaked at $1.95M in Q2 2021.
  • 303 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.